Release Date: 25/07/19 16:44 Summary: OceanaGold Q2 2019 MD&A Price Sensitive: Yes Download Document 1.04MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling